Medicine changes lives.
Research changes the world.
Every day, Mass General Brigham scientists chart new terrain in biomedical research to prevent and treat human disease and advance patient care — locally and across the globe.
Recent News
Tips to Help Scientists Get the Most out of Twitter
Twitter can be a great platform for scientists to connect with colleagues, start new collaborations and engage with the public.
Revisions to State Licensing Questions Could Help More Doctors Access Mental Health Services
Changing the scope and nature of questions about mental health on licensing applications could make doctors more comfortable seeking care.
Introducing the 2021 Mass General Research Institute Image Awards
Check out the new categories and contest rules for the 2021 MGRI Image Awards!
One More Question: A Mass General Research Fellow’s Prizewinning Essay on Health Equity
Trisha Pasricha, MD, shares an eye-opening patient experience that illustrated the stark effect of COVID-19 disparities.
Conversations with Margarita: The Future of the American Dream
While they drive our economy and society forward, people who immigrate to the United States also have to navigate new systems, cultural norms, and sometimes a new language.
Congratulations to the 2021 Class of Bridging Academia with Industry
The translational research training program and accompanying project competition seeks to create a new culture of research collaboration.
Alzheimer’s and Brain Awareness Month 2021: Spotlighting Mass General Alzheimer’s Researchers (Part 2)
In the second installment, we highlight two more approaches to Alzheimer’s research with Drs. Susanne Janneke Van Veluw and Mehdi Jorfi.
Alzheimer’s and Brain Awareness Month 2021: Spotlighting Mass General Alzheimer’s Researchers
Learn how Mass General researchers are working to develop new treatments and diagnostic tools for Alzheimer’s disease and dementia.
Decrease in Internet Searches for Cancer Screening Terms During COVID Sparks Concerns of Delayed Diagnoses
Researchers are worried that delayed cancer screenings due to COVID could lead to later diagnoses and more severe cases.